Skip to content

Effect of Massage Treatment in Temporomandibular Joint

Effect of Massage Treatment in Patients With Temporomandibular Disorder

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04132726
Acronym
TMD
Enrollment
90
Registered
2019-10-21
Start date
2018-04-17
Completion date
2019-10-02
Last updated
2019-10-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Massage Therapy, Temporomandibular Disorder

Keywords

Massage

Brief summary

Temporomandibular disorders (TMD) have multiple and broad clinical effects on orofacial structures and are often diagnosed in patients with a prevalence of between 5% and 12%. Among treatment options, massage therapy is one of the common therapeutic procedures and allows interesting clinical outcomes by reducing TMD symptoms successfully. However, there has been no attempt to validate this knowledge. Thus, the aim of this study is to evaluate the effect of massage and its properties in patients with TMD.

Interventions

OTHERMassage therapy

Massage therapy performed by a physiotherapist

OTHERnon-effective treatment

non-effective treatment

Sponsors

Istanbul University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to 40 Years
Healthy volunteers
Yes

Inclusion criteria

1. Temporomandibular disorder-positive RDC/TMD examination for groups RDC/TMD Ia and RDC/TMD Ib, 2. Patient agreement to participate in the experimental study.

Exclusion criteria

1. RDC/TMD II and RDC/TMDIII, 2. Drug and/or removable partial or total prosthesis wearers, 3. Being submitted to any type of physiotherapeutic treatment, 4. Incomplete dentition, 5. History of systemic diseases as diabetes or arthritis, 6. The occurrence of facial trauma, 7. Refusal to assume responsibility with this research.

Design outcomes

Primary

MeasureTime frameDescription
Pain- Visual Analog Scale12 weeks-14 weeksSelf-reported pain values. High scores for pain mean worse outcome for the study.

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026